GlassScriptPhysician profile
James G Evans
NPI 1417287947
$1,332.89
in general payments reported to CMS, 2019-2025
11 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $371 · 2022: $460 · 2023: $120 · 2024: $273 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $230.75 | 2021-2025 | Grafix Pl, Stravix Pl, Oasis Micro |
| Astrazeneca Pharmaceuticals LP | $204.93 | 2021-2022 | |
| Genzyme Corporation | $191.99 | 2022 | |
| Gilead Sciences, INC. | $154.91 | 2024-2025 | Veklury, Livdelzi |
| Glaxosmithkline, LLC. | $120.86 | 2024 | Nucala |
| Jazz Pharmaceuticals INC. | $119.74 | 2021 | |
| Medical Device Business Services, INC. | $99.74 | 2023 | Linx Reflux Management System |
| Eisai INC. | $89.67 | 2021 | |
| Novo Nordisk INC | $80.23 | 2021-2022 | |
| Integra Lifesciences Corporation | $24.82 | 2022 | |
| Medela LLC | $15.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.